News & Updates

Show Multimedia Only
Trabectedin fails to improve survival outcomes in recurrent ovarian, primary peritoneal, or fallopian tube cancer

Trabectedin fails to improve survival outcomes in recurrent ovarian, primary peritoneal, or fallopian tube cancer

07 Sep 2022
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients

IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients

07 Sep 2022